The report uses data reported on FAERS data base (FDA adverse event reporting site) to show that Linzess is the primary suspect in 7 deaths, 85 hospitalizations, 16 disabilities, and 10 adverse events that required intervention in just 3 years since its launch in 2013.
good move - its going to take a LOT of cake to ice this over
And the shorting has obviously continuing today. The geniuses who bought into the Synergy pump-and-dump have obviously deduced that with plecanatide's NDA having been accepted, the millions of people who have been taking Linzess have decided they can wait until 2017 to have their next bowel movement. I am adding here at 10.39.
ironwood is DOWN an appalling 8.4%
synergy is UP an appealing 21.5%
further selective minutely updates as warranted
Bleeker bear takes this and is reminiscent of the bear on the Charmin commercial, who is wiping himself
I think you should stay on this board rather than spread lies and try to deceive any and everybody into thinking your product holds water to Plecanatide....you...little man are going to join the unemployment line along with the shills you hired to plague the SGYP board.
Sentiment: Strong Sell
feels like P&D time. enjoy